Medpace Raises Outlook On Gains in New Business Awards

Dow Jones

Jul 22, 2025

Medpace raised its full-year outlook after it reported a second-quarter profit that beat analysts' expectations boosted by gains in new business awards.

Medpace shares surged 46% in premarket.

The clinical research company on Monday reported $90.3 million in net income, or $3.10 a share, up from $88.4 million, or $2.75 a share, from the prior year. Analysts expected $2.98 a share.

Medpace reported $603.3 million in revenue, beating Wall Street's expectations of $539 million and up from $528.1 million the year prior. Net new business awards were $620.5 million, up from $551 million in the second quarter of 2024.

The company raised its 2025 earnings per share guidance to $13.76 to $14.53, up from a range of $12.26 to $13.04.

It also increased its revenue forecast to between $2.42 billion and $2.52 billion, which would represent growth of 14.7% to 19.5% from 2024 revenue.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2553640146"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2553640146\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2553640146?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-22 16:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553640146","market":"sg","top_or_hot":-1,"title":"Medpace Raises Outlook On Gains in New Business Awards","media":"Dow Jones","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/MEDP\">Medpace</a> raised its full-year outlook after it reported a second-quarter profit that beat analysts&#39; expectations boosted by gains in new business awards.</p><p>Medpace shares surged 46% in premarket.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/ce51dd33effec62a9b581584ed434f79\" tg-width=\"531\" tg-height=\"158\"/></p><p>The clinical research company on Monday reported $90.3 million in net income, or $3.10 a share, up from $88.4 million, or $2.75 a share, from the prior year. Analysts expected $2.98 a share.</p><p>Medpace reported $603.3 million in revenue, beating Wall Street&#39;s expectations of $539 million and up from $528.1 million the year prior. Net new business awards were $620.5 million, up from $551 million in the second quarter of 2024.</p><p>The company raised its 2025 earnings per share guidance to $13.76 to $14.53, up from a range of $12.26 to $13.04.</p><p>It also increased its revenue forecast to between $2.42 billion and $2.52 billion, which would represent growth of 14.7% to 19.5% from 2024 revenue.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medpace Raises Outlook On Gains in New Business Awards</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedpace Raises Outlook On Gains in New Business Awards\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-07-22 16:02</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><a href=\"https://laohu8.com/S/MEDP\">Medpace</a> raised its full-year outlook after it reported a second-quarter profit that beat analysts&#39; expectations boosted by gains in new business awards.</p><p>Medpace shares surged 46% in premarket.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/ce51dd33effec62a9b581584ed434f79\" tg-width=\"531\" tg-height=\"158\"/></p><p>The clinical research company on Monday reported $90.3 million in net income, or $3.10 a share, up from $88.4 million, or $2.75 a share, from the prior year. Analysts expected $2.98 a share.</p><p>Medpace reported $603.3 million in revenue, beating Wall Street&#39;s expectations of $539 million and up from $528.1 million the year prior. Net new business awards were $620.5 million, up from $551 million in the second quarter of 2024.</p><p>The company raised its 2025 earnings per share guidance to $13.76 to $14.53, up from a range of $12.26 to $13.04.</p><p>It also increased its revenue forecast to between $2.42 billion and $2.52 billion, which would represent growth of 14.7% to 19.5% from 2024 revenue.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2553640146","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553640146","pubTimestamp":1753171356,"columns":[{"name":"Data Report","id":30,"label_key":"dataReport"}],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Medpace raised its full-year outlook after it reported a second-quarter profit that beat analysts' expectations boosted by gains in new business awards.The clinical research company on Monday reported $90.3 million in net income, or $3.10 a share, up from $88.4 million, or $2.75 a share, from the prior year. Analysts expected $2.98 a share.Medpace reported $603.3 million in revenue, beating Wall Street's expectations of $539 million and up from $528.1 million the year prior. Net new business awards were $620.5 million, up from $551 million in the second quarter of 2024.The company raised its 2025 earnings per share guidance to $13.76 to $14.53, up from a range of $12.26 to $13.04.It also increased its revenue forecast to between $2.42 billion and $2.52 billion, which would represent growth of  14.7% to 19.5% from 2024 revenue.The stock rose 45% in late trading to $448 following the earnings beat.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4585":"ETF&股票定投概念","LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","MEDP":"Medpace Holdings Inc.","LU2065171311.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","BK4121":"生命科学工具和服务","LU2065169927.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","LU2065171402.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC"},"translate_title":"Medpace上调新业务奖项增长前景","themeId":"eec706e52161d0d21ad91bcc8a155144","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MEDP":1},"content_text":"Medpace raised its full-year outlook after it reported a second-quarter profit that beat analysts' expectations boosted by gains in new business awards.Medpace shares surged 46% in premarket.The clinical research company on Monday reported $90.3 million in net income, or $3.10 a share, up from $88.4 million, or $2.75 a share, from the prior year. Analysts expected $2.98 a share.Medpace reported $603.3 million in revenue, beating Wall Street's expectations of $539 million and up from $528.1 million the year prior. Net new business awards were $620.5 million, up from $551 million in the second quarter of 2024.The company raised its 2025 earnings per share guidance to $13.76 to $14.53, up from a range of $12.26 to $13.04.It also increased its revenue forecast to between $2.42 billion and $2.52 billion, which would represent growth of 14.7% to 19.5% from 2024 revenue.","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}